News release 2023 Covis Announces Successful Completion of Its Previously Announced Financial Recapitalization Transaction, Resulting in a Material Strengthening of Its Financial Position June 1, 2023 Covis Statement on FDA Decision to Withdraw Approval of Makena® April 7, 2023 Covis Announces Signing of Support Agreements With Its Lenders and Equity Sponsors, Leading to a Material Strengthening of Its Financial Position, Including the Elimination of ~$450 Million of Debt April 3, 2023 Covis Pharma Responds to Presiding Officer’s Report Summarizing FDA Advisory Committee Hearing March 7, 2023 News release Contact Us 2023 2022 2021 2020 2018 2017 2015 2013
Covis Announces Successful Completion of Its Previously Announced Financial Recapitalization Transaction, Resulting in a Material Strengthening of Its Financial Position June 1, 2023
Covis Announces Signing of Support Agreements With Its Lenders and Equity Sponsors, Leading to a Material Strengthening of Its Financial Position, Including the Elimination of ~$450 Million of Debt April 3, 2023
Covis Pharma Responds to Presiding Officer’s Report Summarizing FDA Advisory Committee Hearing March 7, 2023
Click here for Canada website